(Q36377285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

EAACI/GA2LEN/EDF guideline: management of urticaria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Carsten Bindslev-Jensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Giorgio Walter Canonica

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bettina Wedi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

M W Greaves

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

9

M Maurer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

C E H Grattan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

B M Henz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Kapp

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M M A Kozel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

H F Merk

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Schäfer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

D Simon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G A Vena

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

EAACI/GA2LEN/EDF

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Zuberbier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

321-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16436141%20AND%20SRC:MED&resulttype=core&format=json

Management of urticaria: a consensus report

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Chronic urticaria and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Helicobacter pylori infection in skin diseases: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Plasmapheresis for severe, unremitting, chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Indications and action mechanisms of phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

The impact of chronic urticaria on the quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

The extent and nature of disability in different urticarial conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Prevention of acute urticaria in young children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Famotidine in the treatment of acute urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Review of fexofenadine in the treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Stanozolol in chronic urticaria: a double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Warfarin treatment of chronic idiopathic urticaria and angio-oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Inhibition of cold urticaria by desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Mizolastine in primary acquired cold urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Diagnosis and treatment of solar urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X

Zafirlukast has no beneficial effects in the treatment of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2005.00962.X